Cantor Fitzgerald initiated coverage of Trulieve Cannabis Corp. on July 20, 2026. The firm assigned the stock an Overweight rating.
Analysts established a price target of $15.00 per share. This valuation suggests significant upside potential compared to the company's recent trading levels.
The Overweight rating indicates Cantor Fitzgerald's expectation that Trulieve will outperform its sector or the broader market. This new coverage arrives as the company navigates the evolving regulatory landscape of the U.S. cannabis industry.